EM2109E "CAR T cell therapy - the future beyond hematological malignancies!" (IM GR-092421)
This presentation will provide the current understanding of treatment landscape in FDA Approved CAR-T Cell Therapy. Listeners will be able to understand the barriers in wide-scale implementation of CAR-T therapy along with potential solutions to expand utilization beyond hematological malignancies
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Describe the current treatment landscape of CAR-T Cell therapy in FDA approved indications
- Explain the applicability of CAR-T Cell therapy in non-hematological indications
- Identify the challenges and solutions facing future wide-scale implementation of CAR-T Cell therapy
Ankit Kansagra, M.D.
Assistant Professor of Internal Medicine
Division of Hematology and Oncology
- 1.00 AMA